Current Studies

Data Elements: Studies.aspx

Low Testosterone

Low Testosterone and Adverse Outcomes

Although low testosterone is common among middle aged and older men, supplementing testosterone therapy is considered to carry risks such as heart attacks or strokes. Northwest Clinical Research Center is involved in assessing such risks with a testosterone gel among middle aged and older men.

Testosterone replacement therapies are known for helping with such factors as libido, mood regulation, maintenance of sexual characteristics and sperm development and are thus widely used by men with Low T. However, existing clinical trial data do not specifically assess risks associated with long-term use of testosterone replacement medications. Thus, further research on this important topic is needed.

About the Study Medication

The current study is further evaluating a testosterone replacement therapy that is approved by the U.S. Food and Drug Administration.

Specifically, this is a long-term study to evaluate if use of Androgel 1.62%® is associated with increased cardiovascular events over a period of five years. 


  • Candidates who are ages 45-80 with Testosterone levels < 300 ng/dL.
  • Low testosterone levels and some cardiovascular risk factors (hypertension, coronary artery disease, current smoker, diabetes).


No Cost Study

There is no cost to participate in the study, and the study participant will receive the following:

  • Medical evaluation.
  • Investigational Medication.
  • Study Related Medical Care.
  • Compensation up to $1,000.
  • Complimentary transportation or a travel stipend.

Speak with one of our Recruitment Specialists

Please contact us by filling out the Contact Us web form, or by calling 1-425-453-0404 anytime.

Contact Us
425.453.0404 | 1951 152nd Pl NE Suite 200 Bellevue, WA 98007
© 2019 All Rights Reserved. Website by Efinitytech